Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
Shares of Edwards Lifesciences Corp. EW advanced 2.94% to $73.22 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.53% to ...
11 Analysts Have This To Say About Edwards Lifesciences
In the latest quarter, 11 analysts provided ratings for Edwards Lifesciences EW, showcasing a mix of bullish and bearish ...
CVS upgraded to buy by Edward Jones over potential turnaround
Edward Jones has upgraded CVS Health (CVS) to buy from hold, citing a potential turnaround in its Aetna insurance business. Read more here.
EQS-News: Affluent Medical announces 10th successful human implantation of its Artus urinary sphincter, marking completion of the pilot phase
The tenth implantation of the Artus artificial urinary sphincter was successfully performed in the second week of January 2025 in Poland, marking the end of patient enrollment for the pilot phase. The ...
German medical device firm Medability selects Tampa for US headquarters
Medability GmbH, a German medical technology company, will establish its U.S. headquarters in Tampa. It's the latest foreign ...
Edwards Lifesciences upped to Buy at Stifel on TAVR growth
Edwards Lifesciences (NYSE: EW) stock rises after Stifel upgrades to Buy, citing potential for TAVR growth acceleration in 2025. Read more here.
Stifel raises Edwards Lifesciences stock to buy, target to $90
Stifel analysts upgraded Edwards Lifesciences (NYSE:EW) stock from Hold to Buy, citing potential growth acceleration in the Transcatheter Aortic Valve Replacement (TAVR) market. The firm also ...